Orientation of epitopes influences the immunogenicity of synthetic peptide dimmers
Orientation of epitopes influences the immunogenicity of synthetic peptide dimmers
复制标题
表位的方向影响合成肽二聚体的免疫原性
DOI:
--
复制
发表时间:
1988
影响因子:
5.4
通讯作者:
M. Francis
中科院分区:
文献类型:
--
作者:
J. Cox;J. Ivanyi;D. Young;J. Lamb;A. Syred;M. Francis
The immunogenicity of synthetic peptide dimers based on epitope sequences derived from the mycobacterial 65‐kDa antigen and the foot and mouth disease virus (FMDV) VP1 protein was examined in inbred mice. The analysis was directed towards the potential helper role of a T cell stimulatory mycobacterial epitope (65–85) with respect to poorly immunogenic sites either from the same molecule (422–436) or from VP1 (141–160). The 65–85 repeat homodimer induced an antibody response in CBA/ca but not in C57BL/6 mice, both nonresponders to the 65–85 monomer, and amplified the antibody response in BALB/c, monomer‐responder mice. Analysis of the immunogenicity of hybrid dimers in BALB/c mice showed that the orientation of peptides within the dimer is critical for the extent of the produced antibody response. Only the 422–436/65–85 but not the 65–85/422–436 induced antibodies binding to the 422–436 sequence which was nonimmunogenic when injected either as a monomer or dimer. Despite the striking difference in immunogenicity, both tested hybrid dimers reacted equally in the solid‐phase immunoassay with antisera raised to 65–85‐dimer or 422–436/65–85 peptides or with a monoclonal antibody to the 422–436 epitope. The described differences in antibody responsiveness also cannot be attributed merely to the extent of T cell stimulation since the proliferative responses were uniformly expressed for all relevant combinations of peptides. Antisera to 65–85 dimer and 422–436165–85 hybrid also reacted with the native 65‐kDa protein. Furthermore, the production of FMDV‐neutralizing antibodies in response to the 141–160 (VP1‐derived)/ 65–85 hybrid peptide in 141–160 nonresponder B10.D2 mice also confirmed the helper activity of the 65–85 epitope. Thus, combining heterologous peptides with the N‐terminal of the mycobacterial 65–85 sequence may be generally applicable for the potentiation of peptide vaccines.
DOI:
10.1073/pnas.83.18.7013
发表时间:
1986-09-01
影响因子:
11.1
作者:
MEHRA, V;SWEETSER, D;YOUNG, RA
通讯作者:
YOUNG, RA
DOI:
10.1073/pnas.82.15.5131
发表时间:
1985-01-01
影响因子:
11.1
作者:
HOUGHTEN, RA
通讯作者:
HOUGHTEN, RA
DOI:
--
发表时间:
1985
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Heber-Katz,E;Hollosi,M;Dietzschold,B;Hudecz,F;Fasman,GD
通讯作者:
Fasman,GD